- Lobbying
- Lobbying by Eli Lilly & Co.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Phil Cox | n/a |
Larissa Martin | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Trade (Domestic & Foreign)
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Trade (Domestic & Foreign)
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Trade (Domestic & Foreign)
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Trade (Domestic & Foreign)
Q3 Report
Lobbying Issues
Agencies Lobbied
Executive Office of the President (EOP)
Office of Management & Budget (OMB)
Office of the Vice President of the United States
Type of Issue
Lobbying Issues
Agencies Lobbied
Health & Human Services - Dept of (HHS)
Office of the Vice President of the United States
Executive Office of the President (EOP)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Executive Office of the President (EOP)
Commerce - Dept of (DOC)
U.S. Trade Representative (USTR)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Taxation
Trade (Domestic & Foreign)
Registration
Issue(s) they said they’d lobby about: drug pricing, Japan - pricing reform internationally.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate